DAYMARK WEALTH PARTNERS, LLC

Position in NVS — Novartis AG

CIK 1956824 CINCINNATI, OH

Position in NVS

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$6,872,485

+$1,862,133 QoQ

Shares Held

43,852

+33.7% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#221

of 1,603 holders

Holding Since

Dec 2022

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

DAYMARK WEALTH PARTNERS, LLC holds $218,773,359 across 12 Drug Manufacturers - General names. NVS ranks #6 (3.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	266,410	$67,660,147
2	AMGN	Amgen Inc	150,438	$54,476,608
3	ABBV	AbbVie Inc.	130,459	$32,828,702
4	LLY	ELI LILLY & Co	25,552	$30,647,837
5	MRK	Merck & Co., Inc.	81,443	$10,465,425
6	NVS	Novartis AG This page	43,852	$6,872,485
7	BMY	Bristol Myers Squibb Co	85,038	$4,899,889
8	PFE	Pfizer Inc	173,196	$4,170,559

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,872,485	43,852	+33.7%	Shares	Sole	2026-07-31
2026-03-31	$5,010,352	32,801	+0.2%	Shares	Sole	2026-05-11
2025-12-31	$4,511,520	32,723	-1.0%	Shares	Sole	2026-01-12
2025-09-30	$4,239,614	33,060	-0.7%	Shares	Sole	2025-10-22
2025-06-30	$4,030,480	33,307	+12.5%	Shares	Sole	2025-08-04
2025-03-31	$3,299,585	29,598	+1.1%	Shares	Sole	2025-04-23
2024-12-31	$2,848,458	29,272	+5.0%	Shares	Sole	2025-01-17
2024-09-30	$3,206,412	27,877	+3.9%	Shares	Sole	2024-10-08
2024-06-30	$2,855,363	26,821	+10.5%	Shares	Sole	2024-08-14
2024-03-31	$2,348,314	24,277	+3.7%	Shares	Sole	2024-04-10
2023-12-31	$2,364,818	23,421	+4.5%	Shares	Sole	2024-01-09
2023-09-30	$2,283,701	22,420	+0.3%	Shares	Sole	2023-10-10
2023-06-30	$2,255,540	22,352	+2.4%	Shares	Sole	2023-07-19
2023-03-31	$2,008,636	21,833	+3.5%	Shares	Sole	2023-04-20
2022-12-31	$1,914,101	21,099	—	Shares	Sole	2023-01-25
No filing history on record for this holder in this stock.